Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Phase 2/3, Study to Evaluate the Efficacy and Safety of an Intraarticular Injection of GNSC-001 in Participants With Osteoarthritis of the Knee

NCT07831577 is registered in ClinicalTrials.gov with Genascence Corporation as lead sponsor.

NCT NCT07831577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07831577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Phase 2/3, Study to Evaluate the Efficacy and Safety of an Intraarticular Injection of GNSC-001 in Participants With Osteoarthritis of the Knee
Lead sponsor
Genascence Corporation
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
July 31, 2027
Completion date
October 31, 2030
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthritis, knee arthritis disease, knee arthritis osteoarthritis, knee arthritis, osteoarthritis, osteo arthritis knee, osteo arthritis of the knee, osteoarthritic knee pain, osteoarthritis (oa) of the knee, pain (knee)